Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Upton

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2016
Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular EndotheliumSarah L Appleby, Claudia-Gabriela Mitrofan, Alexi Crosby, et al.
American Journal of Respiratory Cell and Molecular Biology|February 13, 2001
Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulationsP D Upton, J Wharton, H Coppock, et al.
The Journal of Pathology|November 10, 2007
Regulation of bone morphogenetic protein signalling in human pulmonary vascular developmentM Southwood, T K Jeffery, X Yang, et al.
Cardiovascular Research|April 16, 2024
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transportBin Liu, Mujahid Azfar, Ekaterina Legchenko, et al.
Plos One|March 22, 2014
Transcript analysis reveals a specific HOX signature associated with positional identity of human endothelial cellsMark Toshner, Benjamin J Dunmore, Eoin F McKinney, et al.
The Journal of Biological Chemistry|September 28, 2010
Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type IIHannah J Durrington, Paul D Upton, Simon Hoer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2026
Interleukin-6 is critical in the development of pulmonary vascular disease in <i>Gcn2-</i>deficient miceMax Schwiening, Qingyue Gao, Mark Southwood, et al.
Circulation|February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Molecular Genetics & Genomic Medicine|April 9, 2021
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in childrenJoshua Hodgson, Lidia Ruiz-Llorente, Jamie McDonald, et al.
Angiogenesis|November 12, 2025
BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivityBenjamin J Dunmore, Stephen Moore, Rowena J Jones, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2016
Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular EndotheliumSarah L Appleby, Claudia-Gabriela Mitrofan, Alexi Crosby, et al.
American Journal of Respiratory Cell and Molecular Biology|February 13, 2001
Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulationsP D Upton, J Wharton, H Coppock, et al.
The Journal of Pathology|November 10, 2007
Regulation of bone morphogenetic protein signalling in human pulmonary vascular developmentM Southwood, T K Jeffery, X Yang, et al.
Cardiovascular Research|April 16, 2024
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transportBin Liu, Mujahid Azfar, Ekaterina Legchenko, et al.
Plos One|March 22, 2014
Transcript analysis reveals a specific HOX signature associated with positional identity of human endothelial cellsMark Toshner, Benjamin J Dunmore, Eoin F McKinney, et al.
The Journal of Biological Chemistry|September 28, 2010
Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type IIHannah J Durrington, Paul D Upton, Simon Hoer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2026
Interleukin-6 is critical in the development of pulmonary vascular disease in <i>Gcn2-</i>deficient miceMax Schwiening, Qingyue Gao, Mark Southwood, et al.
Circulation|February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Molecular Genetics & Genomic Medicine|April 9, 2021
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in childrenJoshua Hodgson, Lidia Ruiz-Llorente, Jamie McDonald, et al.
Angiogenesis|November 12, 2025
BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivityBenjamin J Dunmore, Stephen Moore, Rowena J Jones, et al.
Pageof 16